Author Question: A child is prescribed an inhaled corticosteroid agent to decrease respiratory inflammation. The ... (Read 61 times)

Kikoku · **on:** Jul 23, 2018

A child is prescribed an inhaled corticosteroid agent to decrease respiratory inflammation. The child's parent administers high doses of the drug after 2 days of administration. What is the patient at risk for?

A) Adrenal insufficiency
B) Tachycardia
C) Edema
D) Hypoglycemia

Question 2

A patient has been largely unsuccessful in achieving adequate control of dyslipidemia through lifestyle changes and the use of a statin. As a result, the patient has been prescribed cholestyramine (Prevalite, Questran).

What change in this patient's lipid profile will the nurse identify as the most likely goal of therapy? A) Reduction in triglycerides
B) Reduction in total serum cholesterol levels
C) Increase in HDL levels
D) Reduction in LDL cholesterol levels

FergA · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

A
Feedback:
Adrenal insufficiency is most likely to occur with systemic or high doses of inhaled corticosteroids. The patient is not at risk for tachycardia, edema, or hypoglycemia unless related to adrenal insufficiency.

Answer to Question 2

D
Feedback:
Cholestyramine (Prevalite, Questran), the prototype bile acid sequestrant, has the ability to reduce LDL cholesterol. It has little or no effect on HDL cholesterol and either no effect or an increased effect on triglyceride levels.